Objective To appraise the data on systemic adverse effects of inhaled corticosteroids.
Methods A computerized database search from January 1, 1966, through July 31, 1998 …

Background In recent years, clinical trials and observational studies have raised concerns
about the potential adverse effects of inhaled corticosteroids (ICS) such as pneumonia …

Aims There is evidence that large doses of inhaled corticosteroids lead to an increased risk
of glaucoma, cataracts and other problems associated with oral corticosteroid use. However …

OBJECTIVE: Until recently, inhaled corticosteroids were not considered to cause elevated
intraocular pressure (IOP), although topical and oral corticosteroids have been shown to do …

Adrenocortical suppression as a consequence of corticosteroid therapy is a well-known and
serious systemic adverse effect. Although the risk of adrenocorticai suppression during the …

Sažetak The aim of this study was to examine whether any correlation exists between long
term use of high doses of inhaled corticosteroids and the occurrence of intraocular …

Conclusion: Timolol significantly affects the cardiopulmonary status. Therefore, we could
advice the assessment of cardiopulmonary status mandatory in patients receiving topical …

Objective.—To determine whether the use of inhaled and nasal glucocorticoids is
associated with an increased risk of ocular hypertension or open-angle glaucoma. Design …

Purpose: To ascertain the incidence of posterior subcapsular cataract and ocular
hypertension in a cohort of children⩽ 12 years on inhaled steroid therapy. Patients and …

The risk of steroid-induced elevation of intraocular pressure and glaucoma is clinical
relevant and require monitoring of patients at risk. The risk depends on route of …